1. 128 SINGLE CENTER EXPERIENCE OF RIC BASED ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN 100 PATIENTS WITH MDS. Issue 1 (April 2015) Authors: Blaise, D.; Saillard, C.; Fürst, S.; Faucher, C.; Prebet, T.; El Cheikh, J.; Castagna, L.; Charbonnier, A.; Granata, A.; Rey, J.; Devillier, R.; Mohty, B.; Arnoulet, C.; Moziconnaci, M.J.; Chabannon, C.; Vey, N. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 14 A PHASE 2, DOSE-FINDING STUDY OF SOTATERCEPT (ACE-011) IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) OR NON-PROLIFERATIVE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) AND ANEMIA REQUIRING TRANSFUSION. (April 2015) Authors: Komrokji, R.; Garcia-Manero, G.; Ades, L.; Laadem, A.; Vo, B.; Prebet, T.; Stamatoullas, A.; Boyd, T.; Delaunay, J.; Steensma, D.P.; Sekeres, M.A.; Beyne-Rauzy, O.; Zou, J.; Attie, K.M.; Sherman, M.L.; Fenaux, P.; List, A.F. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 5 SUPPORTIVE CARE INCLUDING CHELATION. (April 2015) Authors: Prebet, T. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Validation of a Post-Hypomethylating Agent Failure (HMAF) Prognostic Model in MDS Patients Treated with Rigosertib Versus Best Supportive Care (BSC). (April 2017) Authors: Nazha, A.; Sekeres, M.; Komrokji, R.; Steensma, D.; Kantarjian, H.; Roboz, G.; Fenaux, P.; Prebet, T.; Azarnia, N.; Zbyszewski, P.; Fruchtman, S.; Santini, V.; Silverman, L.; Platzbecker, U.; Garcia-Manero, G. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Evaluation of Salvage Induction Chemotherapy Regimens in Myelodysplastic Syndrome and Acute Myeloid Leukemia after Hypomethylating Agent Treatment Failure. (April 2017) Authors: Ball, B.; Komrokji, R.; Adès, L.; Sekeres, M.; DeZern, A.; Pleyer, L.; Vey, N.; Almeida, A.; Germing, U.; Cluzeau, T.; Platzbecker, U.; Gore, S.; Fenaux, P.; Prebet, T. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P498: CLINICAL AND BIOLOGICAL MARKERS ASSOCIATED WITH LONG-TERM SURVIVAL FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN REMISSION AFTER CHEMOTHERAPY IN THE QUAZAR AML-001 TRIAL OF ORAL AZACITIDINE. (23rd June 2022) Authors: Wei, A. H.; Döhner, H.; Sayar, H.; Ravandi, F.; Montesinos, P.; Dombret, H.; Selleslag, D.; Porkka, K.; Jang, J.-H.; Skikne, B.; Beach, C.; Prebet, T.; Zhang, G.; Risueño, A.; Ugidos Guerrero, M.; See, W. L.; Menezes, D.; Roboz, G. J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P499: THE PHASE 1B OMNIVERSE TRIAL OF ORAL AZACITIDINE IN COMBINATION WITH VENETOCLAX FOR TREATMENT OF RELAPSED/REFRACTORY OR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (TRIAL IN PROGRESS). (23rd June 2022) Authors: Wei, A. H.; Carraway, H. E.; Taningco, L.; Laille, E.; Gong, J.; Prebet, T.; Lopes de Menezes, D.; Ravandi, F. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P570: REAL-WORLD EFFICACY OUTCOMES OF VENETOCLAX PLUS AZACITIDINE VS INTENSIVE CHEMOTHERAPY FOR INDUCTION THERAPY IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA. (23rd June 2022) Authors: Zeidan, A. M.; Pollyea, D. A.; Borate, U.; Vasconcelos, A.; Potluri, R.; Rotter, D.; Kiendrebeogo, Z.; Gaugler, L.; Bonifacio, G.; Prebet, T.; Chen, C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P571: ORAL AZACITIDINE VS MIDOSTAURIN AS MAINTENANCE TREATMENT FOR FLT3 MUTANT ACUTE MYELOID LEUKEMIA IN COMPLETE REMISSION: AN INDIRECT TREATMENT COMPARISON. (23rd June 2022) Authors: Oliva, E. N.; Chen, C.; Rahim, S. N.; Seuro, B.; Vasconcelos, A.; Gaugler, L.; Skikne, B.; Prebet, T.; Cameron, H.; Beach, C.; Thompson, G. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 470 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗